MET targeted therapy for lung cancer: clinical development and future directions
{{output}}
MET, the receptor for hepatocyte growth factor, has been identified as a novel promising target in various human malignancies, including lung cancer. Research studies have demonstrated that MET signaling plays important physiologic roles in embryogenesis and e... ...